MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

acv1 phase 2a results, page-2

  1. 97 Posts.
    Remeber the obesity thing where the sell-off came before the release of results for the so-called "double blind" study. I would never have confidence in this company again, it cost me alot.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.